Parallel Advisors’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51K | Sell |
74
-859
| -92% | -$17.5K | ﹤0.01% | 3085 |
|
|
2025
Q1 | $16.9K | Buy |
933
+854
| +1,081% | +$15.5K | ﹤0.01% | 2207 |
|
|
2024
Q4 | $2K | Buy |
79
+57
| +259% | +$1.44K | ﹤0.01% | 2947 |
|
|
2024
Q3 | $748 | Hold |
22
| – | – | ﹤0.01% | 3080 |
|
|
2024
Q2 | $814 | Hold |
22
| – | – | ﹤0.01% | 2993 |
|
|
2024
Q1 | $923 | Hold |
22
| – | – | ﹤0.01% | 2950 |
|
|
2023
Q4 | $873 | Hold |
22
| – | – | ﹤0.01% | 2967 |
|
|
2023
Q3 | $605 | Hold |
22
| – | – | ﹤0.01% | 3071 |
|
|
2023
Q2 | $746 | Sell |
22
-2
| -8% | -$68 | ﹤0.01% | 3004 |
|
|
2023
Q1 | $864 | Hold |
24
| – | – | ﹤0.01% | 2992 |
|
|
2022
Q4 | $1.07K | Sell |
24
-2
| -8% | -$89 | ﹤0.01% | 2881 |
|
|
2022
Q3 | $1K | Buy |
26
+4
| +18% | +$154 | ﹤0.01% | 2842 |
|
|
2022
Q2 | $1K | Buy |
+22
| New | +$1K | ﹤0.01% | 2704 |
|